Navigation Links
The Canadian Foundation for Global Health Announces a Research and Development Partnership with Medizone International, Inc.
Date:2/18/2009

OTTAWA, Feb. 18 /PRNewswire-FirstCall/ -- It was announced today that Medizone International's (Pink Sheets: MZEI) AsepticSure(TM) hospital sterilization system is being developed under the direction of Dr. Michael E. Shannon of the Canadian Foundation for Global Health. Dr. Shannon was recently appointed President of the Canadian Foundation for Global Health. He also serves as a board member of Medizone International and is the Company's Director of Medical Affairs.

The Medizone AsepticSure(TM) system is described as a portable decontamination and sterilization system for hospitals, government buildings, schools and other functionally critical environments that might currently require, or need to be prepared for, countermeasures capability from contamination by infectious biological agents such as C difficile, E coli, Pseudomonas aeruginous, MRSA and VRE. The AsepticSure(TM) system is designed to sterilize the space and then return it to full service in two hours or less.

Dr. Shannon stated that "this research partnership is the first for the Foundation and he expects that it will establish a model for other projects in the future. Presently, the Foundation is fully occupied in developing this sterilization program. We are currently identifying principal investigators as well as a suitable research institution at which we plan to focus most of our microbiology for this exciting project. Our intention is to begin independent university trials in the spring with the goal of validating the effectiveness of our new system across a broad range of bacterial and viral pathogens. This will be quickly followed by actual hospital beta testing to confirm the practicability of our decontamination protocols. Based upon innovative new engineering approaches, we remain confident that this research will reliably demonstrate 5 log reductions for most, if not all, of these often fatal bacteria. The implications of such work are indeed profound as these pathogens are considered to be the main causative agents of hospital derived infections and collectively account for tens of thousands of lives lost each year in the US alone. So far we have received a high level of interest from hospitals in both the United States and Canada and expect that if the university trials are as successful as we anticipate, it will be a smooth transition to hospital beta testing of the prototype design which is expected to begin during the 3rd quarter of 2009."

The Canadian Foundation for Global Health is a federally chartered not for profit Canadian Corporation. It has been established to assist in the research and development of novel and advanced emerging technologies in the field of science and medicine deemed to be of benefit to humanity.

Medizone International, Inc., is a research and development stage company engaged in the development of patented and unpatented technologies and protocols for O3 based bio-oxidative treatment of diseases caused by lipid enveloped viruses, including Acquired Immune Deficiency Syndrome (AIDS), Hepatitis B & C, and Herpes, the decontamination of blood, blood products and veterinarian serum products, and the treatment of external pathogenic conditions. It is currently developing technology to decontaminate and sterilize hospital surgical suites, emergency rooms and intensive care units.

This Press Release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company's filings made with the Securities and Exchange Commission.

Contact for the Canadian Foundation for Global Health 613-231-8555

Investor Relations, Medizone International: 800-953-3350 /

web site: www.medizoneint.com


'/>"/>
SOURCE Medizone International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medical research community needs to speak louder to prevent another Canadian brain drain
2. Bioniche Invited to Participate in Canadian Beef Value Chain Roundtable
3. University of Alberta organic chemist receives top young Canadian scientist prize
4. Posit Science Featured in Canadian Documentary on the Brain
5. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
6. Canadian cold/flu breakthrough remedy undergoes NCI-sponsored trial in leukemia patients
7. Natural Nutrition Canadian Subsidiary Signs $50.5 Million (CDN) Five Year European Distribution Contract
8. U of T professor first Canadian woman to win prestigious international science prize
9. Superbugs on the rise in Canadian hospitals, new Queens study shows
10. Leading Insurer Offers Education on How Supplemental Insurance Can Help Offset Challenging Economic Trends in Canadian Market
11. DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... offering education, research and medical media, has launched Contagion® , a ... diseases. , As the all-inclusive resource for infectious disease information, Contagion features ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... company is unveiling its revolutionary new 2.0 version at the International Roofing Expo ... “put the power of the world's most advanced weather technology in the hands ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... Video Remote Interpreting (VRI) within Healthcare, recently partnered with Heart City Health ... (VRI). , For nearly 23 years, Heart City Health Center has provided the ...
(Date:2/10/2016)... Huntington, NY (PRWEB) , ... February 10, 2016 ... ... web-based compliance tracking solution, The Guard, to associations of medical professionals throughout the ... HIPAA compliance, including security risk assessments, policies and procedures, employee training, regulatory updates, ...
(Date:2/10/2016)... ... 10, 2016 , ... Emergency rooms provide emergency care to stabilize critical health ... patients with dental emergencies at risk of losing a tooth or their smiles. Dr. ... , Common dental emergencies include:, , Avulsed or knocked-out teeth ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Calif., Feb. 10, 2016   Genomic Health, Inc. (Nasdaq: ... the quarter and year ended December 31, 2015. ... fourth quarter of 2015, compared with $69.1 million in the fourth ... currency basis, revenue increased 9 percent compared with the same period ... U.S. revenue was $63.9 million in the fourth quarter of ...
(Date:2/10/2016)... 2016 Mylan N.V. (NASDAQ, TASE: MYL) today ... ended December 31, 2015. --> ... total revenues of $9.45 billion, up 28% on a ... revenues of $9.43 billion. Excluding the impact of the ... branded generics business (the "EPD Business"), full year adjusted ...
(Date:2/10/2016)... -- CSI Specialty Group (CSI) expanded its specialty pharmacy ... Pharmacy Podcast. A free, weekly show, the Specialty Pharmacy ... discussion and context amongst specialty pharmacy peers and professionals. ... The Specialty Pharmacy Podcast, hosted by industry leader ... DiMascio, CHE, CMCE, CPC, is available for streaming and/or ...
Breaking Medicine Technology: